Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNAi applications in target validation.

A Kourtidis1, C Eifert, D S Conklin

  • 1Department of Biomedical Sciences, Gen"NY"Sis Center for Excellence Cancer Genomics, University at Albany, Rensselaer, NY 12144, USA.

Ernst Schering Research Foundation Workshop
|January 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of dose, dietary nutrient composition, and supplementation period on the efficacy of methane mitigation strategies in dairy cows: A meta-analysis.

Journal of dairy science·2024
Same author

PPARγ maintains ERBB2-positive breast cancer stem cells.

Oncogene·2013
Same author

New tools for protein linkage mapping and general two-hybrid screening.

Yeast (Chichester, England)·1999
Same author

Messenger RNA editing of the human serotonin 5-HT2C receptor.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·1999
Same author

High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.

Journal of neurochemistry·1999
Same author

MaRX: an approach to genetics in mammalian cells.

Science (New York, N.Y.)·1999

Systems biology and functional genomics accelerate drug discovery by identifying therapeutic targets. RNA interference (RNAi) enables genome-wide screens for pathway elucidation and targeted therapy development.

Area of Science:

  • Systems biology
  • Functional genomics
  • Drug discovery

Background:

  • Systems biology transforms therapeutic target identification.
  • Functional genomics deciphers molecular mechanisms of phenotypes.
  • RNA interference (RNAi) is a key tool in modern biological research.

Purpose of the Study:

  • To provide an overview of systems biology approaches utilizing RNA interference.
  • To demonstrate the application of RNAi in current drug discovery.
  • To explore the future potential of RNAi as a targeted therapy.

Main Methods:

  • Genome-wide screens using RNA interference (RNAi).
  • Interrogation of gene activity to identify molecular mechanisms.
  • Application of functional genomics in model organisms and mammalian cells.

Related Experiment Videos

Main Results:

  • RNAi screens are powerful for elucidating functionally related pathways.
  • Functional genomics has advanced from model organisms to mammalian systems.
  • RNA interference is integral to developing new therapeutic targets.

Conclusions:

  • Systems biology approaches, particularly functional genomics with RNAi, are revolutionizing drug discovery.
  • RNA interference is a validated method for target identification and pathway analysis.
  • RNAi holds significant promise for future targeted therapeutic applications.